Last update 29 May 2025

18-F-fluoroacetate sodium

Overview

Basic Info

Drug Type
Small molecule drug, Diagnostic radiopharmaceuticals
Synonyms-
Target-
Action-
Mechanism-
Therapeutic Areas
NeoplasmsNervous System DiseasesSkin and Musculoskeletal Diseases+ [1]
Active Indication-
Inactive Indication
Adenocarcinoma of prostateHigh Grade Astrocytic TumorLocally advanced breast cancer+ [1]
Originator Organization-
Active Organization-
Inactive Organization
The University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer Center
License Organization-
Drug Highest PhaseDiscontinuedPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

3
Clinical Trials associated with 18-F-fluoroacetate sodium
NCT01320787
/ WithdrawnPhase 1IIT
A Phase I Study of 18-F-Fluoroacetate Sodium as a PET Imaging Agent for Tumor Detection
JPRN-UMIN000008837
/ CompletedPhase 2/3IIT
Positron emission tomography using a newly-developed PET probe: [18F] fluoroacetate (FACE) - clinical patient study - - FACE clinical patient study
JPRN-UMIN000007575
/ CompletedPhase 1IIT
Positron emission tomography using a newly-developed PET probe: [18F] Fluoroacetate (FACE) - human volunteer study - - FACE volunteer study
100 Clinical Results associated with 18-F-fluoroacetate sodium
Login to view more data
100 Translational Medicine associated with 18-F-fluoroacetate sodium
Login to view more data
100 Patents (Medical) associated with 18-F-fluoroacetate sodium
Login to view more data
100 Deals associated with 18-F-fluoroacetate sodium
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Adenocarcinoma of prostatePhase 1-
The University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer Center
01 Oct 2014
High Grade Astrocytic TumorPhase 1-
The University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer Center
01 Oct 2014
Locally advanced breast cancerPhase 1-
The University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer Center
01 Oct 2014
Metastatic Prostate CarcinomaPhase 1-
The University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer Center
01 Oct 2014
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free